Raw Materials & Excipients Management – Page 17

Change impact underestimated during supplier change – risk-based change impact assessment

Assessing Risks of Supplier Changes: A Tactical Playbook In the dynamic landscape of pharmaceutical manufacturing, the impact of raw material changes can be both underestimated and mismanaged, often leading to…

Inadequate vendor qualification during supplier onboarding – evidence pack for vendor oversight

Initial symptoms indicating inadequate vendor qualification can manifest in various ways. Common signals include:Click to read the full article.

Change impact underestimated during post-approval change review – CAPA to prevent repeat failures

Understanding the indicators of process deviations or material issues is essential for timely intervention. Key symptoms that signal potential problems due to underestimated change impacts include:Click to read the full…

Vendor change implemented without approval during supplier onboarding – audit CAPA remediation framework

When a vendor change is implemented without approval, the first signals often manifest during raw material reception or initial processing stages. Symptoms can include:Click to read the full article.

Unapproved material substitution during regulatory inspection – CAPA to prevent repeat failures

Recognizing early warning signs of unapproved material substitution is essential for promptly addressing potential issues. Symptoms may present themselves in various ways:Click to read the full article.

Critical supplier risk not assessed during supply disruption – supplier risk classification strategy

Identifying signals that indicate supplier risk during a supply disruption is crucial. Some common symptoms include:Click to read the full article.

Raw material change implemented without assessment during post-approval change review – risk-based change impact assessment

Recognizing the early signs of potential issues related to unassessed raw material changes is critical. Symptoms may vary across functions; hence, awareness among all team members is key. Here are…

Quality agreement gaps during regulatory inspection – how to prevent repeat supplier failures

Identifying quality agreement gaps begins with recognizing symptoms in the manufacturing process or laboratory environment. Common indicators include:Click to read the full article.

Change impact underestimated during deviation investigation – risk-based change impact assessment

Identifying early symptoms or signals can help in swiftly addressing and mitigating underlying issues related to underestimating change impacts. Symptoms may include the following:Click to read the full article.

Audit response ineffective during supply disruption – inspection questions regulators ask

The first step in any investigation is identifying the symptoms or signals that indicate an audit response has become ineffective during a supply disruption. Below are common signs observed on…

Supplier change not evaluated during regulatory inspection – risk-based change impact assessment

Identifying the early indicators of issues from unassessed supplier changes is critical. Common symptoms include:Click to read the full article.

Critical supplier risk not assessed during supplier onboarding – how to prevent repeat supplier failures

During routine operations or audits, specific signals may indicate a failure to assess critical supplier risks adequately. These symptoms can manifest in various forms:Click to read the full article.